Figure 4.

Assessment of adverse events, medical costs (1€ = 150JPY) and the cumulative dose of prednisolone (PSL) in two groups of patients with active ulcerative colitis (UC) who received GMA or PSL as a treatment intervention. This figure shows GMA has favourable safety over PSL, while the treatment cost is in favour of PSL.

Tominaga et al. BMC Gastroenterology 2013 13:41   doi:10.1186/1471-230X-13-41
Download authors' original image